CSL Limited (ASX:CSL)
CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
CSL Limited (ASX:CSL) share price
CSL Limited (ASX:CSL) share price news
Tech, real estate buoy S&P/ASX200 (ASX:XJO): Bapcor Ltd (ASX:BAP) sinks on slowing sales
The local share market snapped its losing streak, with both the All Ordinaries (INDEXASX: XAO) and S&P/ASX200 (INDEXASX: XJO) gaining 0.4% on a settling of bond yields and the latest Reserve Bank meeting minutes.
Markets hit by risk off sentiment: S&P/ASX 200 (INDEXASX:XJO) down 0.3%
Both the key Australian indices fell on Monday, with the S&P/ASX200 (INDEXASX: XJO) falling 0.3% and the All Ordinaries (INDEXASX: XAO) 0.4% with the technology sector the biggest detractor, down 2.8%.
The Match Out: S&P/ASX 200 (INDEXASX: XJO) flat ahead of US inflation, CSL knocked again
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.037% to 7091.00.
The Match Out: ASX chalks up 5th day of gains
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.68% to 7088.40.
Are Sonic Healthcare Ltd (ASX:SHL) shares a buy today?
Sonic Healthcare Ltd (ASX: SHL) has traditionally viewed as an ASX share that provides a mixture of dividends and defensive growth for investors. However, SHL shares have been sold off 17% over the last 6 months.
Local market marks time ahead of US jobs figure
The Australian sharemarket rebounded from 11-month lows on Thursday, notching a small gain as markets braced for the official US jobs data on Friday night Australian time.
S&P/ASX200 (INDEXASX:XJO) feels the rates heat
The Australia share market retreated to a six-month low on Tuesday, as global markets felt the pressure from surging bond yields – despite, in Australia’s case, the Reserve Bank leaving the official cash rate on hold at 4.1 per cent, for a fifth straight month.
Traders stay on sideline ahead of October rates call
It was relatively quiet on the ASX on Monday with traders eyeing the Reserve Bank of Australia’s latest interest-rate decision, to be announced today (and a public holiday in most states dampening activity further).
Pro Medicus (ASX:PME) shines amid tech sell off: All Ordinaries (ASX:XAO) falls
Pro Medicus Limited (ASX: PME) was a standout, adding 12.4%. The radiology imaging technology firm announced another $140 million ten year contract in the US as the business continues to scale quickly.